CDE Detailed Report
Disease: Parkinson's Disease
Subdomain Name: Imaging Diagnostics
CRF: PET-SPECT Localization
Displaying 1 - 50 of 67
Subdomain Name: Imaging Diagnostics
CRF: PET-SPECT Localization
Displaying 1 - 50 of 67
| CDE ID | CDE Name | Variable Name | Definition | Short Description | Question Text | Permissible Values | Description | Data Type | Disease Specific Instructions | Disease Specific Reference | Population | Classification (e.g., Core) | Version Number | Version Date | CRF Name (CRF Module / Guidance) | Subdomain Name | Domain Name | Size | Input Restrictions | Min Value | Max Value | Measurement Type | External Id Loinc | External Id Snomed | External Id caDSR | External Id CDISC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C08242 | Imaging acquisition duration | ImgAcquisitionDur | Duration of the imaging scan in minutes | Duration of the imaging scan in minutes | Duration of Scan (minutes) | Numeric Values |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-24 11:38:01.2 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
minute | |||||||||
| C18707 | Imaging pre-scan procedure type other text | ImgPrescnProcdrTypOTH | The free-text field related to 'Imaging pre-scan procedure type' specifying other text. Type(s) of pre-scan procedures administered to the participant/subject | The free-text field related to 'Imaging pre-scan procedure type' specifying other text. Type(s) of pre-scan procedures administered to the participant/subject | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-21 16:20:44.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08261 | Imaging radioligand dose value | ImgRadiolgndDosVal | Dose of injected radioligand for the imaging scan | Dose of injected radioligand for the imaging scan | Dose | Numeric Values |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-08-28 16:08:00.453 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
||||||||||
| C59036 | Imaging scan initiation time | ImgScanInitiationTime | Time of scan initiation | Time of scan initiation | Time of Scan Initiation | Date or Date & Time |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-01 16:51:19.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
||||||||||
| C08272 | Imaging F-dopa binding ratio type | ImgFdopaBindRatTyp | Type of F-dopa binding ratio with respect to the rest of the brain | Type of F-dopa binding ratio with respect to the rest of the brain | Fdopa | Striatal (Regional);Putamen;Caudate;Other, specify | Striatal (Regional);Putamen;Caudate;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59050 | Imaging reconstruct image resolution full width half maximum millimeter value | ImgRecImgResFWHMMmVal | Value in millimeters of the reconstructed image resolution measured as full width at half maximum (FWHM) | Value in millimeters of the reconstructed image resolution measured as full width at half maximum (FWHM) | Reconstructed Image Resolution (FWHM) | Numeric Values |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 16:38:19.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
millimeter | |||||||||
| C08243 | Imaging matrix size value | ImgMatrixSizeVal | Value representing the imaging matrix size in millimeters | Value representing the imaging matrix size in millimeters | Image Matrix Size | 64 x 64;128 x 128;512 x 512;Other, specify | 64 x 64;128 x 128;512 x 512;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
millimeter | |||||||
| C18709 | Imaging quantitative outcome type other text | ImgQuantOutcmeTypOTH | The free-text field related to 'Imaging quantitative outcome type' specifying other text. Primary quantitative outcome to describe tracer distribution and uptake for the imaging data analysis | The free-text field related to 'Imaging quantitative outcome type' specifying other text. Primary quantitative outcome to describe tracer distribution and uptake for the imaging data analysis | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 2.00 | 2022-07-22 16:22:28.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08262 | Imaging radioligand dose unit of measure | ImgRadiolgndDoseUoM | Unit of measure for the dose of injected radioligand for the imaging scan | Unit of measure for the dose of injected radioligand for the imaging scan | Unit of Measure | mCi;Mbq;Other, specify | mCi;Mbq;Other, specify | Alphanumeric |
Choose one |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59037 | Medication Parkinsons disease indicator | MedctnParkinsnDzInd | Indicator of whether participant/subject is taking medication for Parkinson's disease | Indicator of whether participant/subject is taking medication for Parkinson's disease | PD Medications | Yes;No | Yes;No | Alphanumeric |
If YES, list the last dose of PD medications. |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-01 16:53:04.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C08276 | Imaging scan aborted reason | ImgAbortRsn | Reason the imaging was aborted | Reason the imaging was aborted | Scan aborted, if check, explain why | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C59051 | Imaging MRI acquire co-registration indicator | ImgMRIAcqCoRegInd | Indicator of whether MRI was acquired for co-registration with the imaging study being documented. | Indicator of whether MRI was acquired for co-registration with the imaging study being documented. | MRI Acquired for Co-registration | No;Yes | No;Yes | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-22 11:17:34.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C08244 | Imaging slice thickness value | ImgSliceThicknessVal | Value of the thickness of the slice measured in millimeters (mm) | Value of the thickness of the slice measured in millimeters (mm) | Slice Thickness (mm) | Numeric Values |
This value should be captured in millimeters (mm) |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-25 08:54:08.2 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
0 | 99 | millimeter | |||||||
| C18710 | Imaging radioligand dose other text | ImgRadiolgndDoseOTH | The free-text field related to 'Imaging radioligand dose unit of measure' specifying other text. Unit of measure for the dose of injected radioligand for the imaging scan | The free-text field related to 'Imaging radioligand dose unit of measure' specifying other text. Unit of measure for the dose of injected radioligand for the imaging scan | Other, specify | Alphanumeric |
Choose one |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2014-05-27 13:34:46.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08263 | Imaging radioligand injection to acquisition duration | ImgRadiolgndInj2AcqDur | Duration in minutes from radioligand injection to imaging acquisition | Duration in minutes from radioligand injection to imaging acquisition | Time from Injection to Scan (minutes) | Numeric Values |
This value should be captured in minutes |
No references available | Adult | Supplemental-Highly Recommended | 4.00 | 2022-07-22 13:31:37.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
minute | |||||||||
| C59038 | Medication Parkinsons disease last dose date time | MedctnParkinsnDzLstDseDateTime | Time (and date, if applicable and known) of most recent Parkinson's disease medication dose | Time (and date, if applicable and known) of most recent Parkinson's disease medication dose | Time of Last Dose | Date or Date & Time |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-06 11:00:26.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
||||||||||
| C18037 | Imaging radioligand specific activity value indicator | ImgRadiolgndSpcfcActValInd | Whether the specific activity value is known | Whether the specific activity value is known | Specific activity of radioligand | Not known | Not known | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-20 10:46:24.96 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59052 | Imaging MRI acquire co-registration date and time | ImgMRIAcqCoRegDateTime | Date (and time, if applicable and known) of MRI acquired for co-registration with the imaging study being documented. | Date (and time, if applicable and known) of MRI acquired for co-registration with the imaging study being documented. | If YES, date of MRI acquisition (mm/dd/yyyy) | Date or Date & Time |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-22 11:24:13.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
||||||||||
| C08246 | Imaging pre-scan procedure type | ImgPrescnProcdrTyp | Type(s) of pre-scan procedures administered to the participant/subject | Type(s) of pre-scan action(s) administered to the participant/subject | Pre-Scan action(s) | Lugols;Perchlorate;Limit sensory stimulation;Other, specify;Carbidopa, specify | Lugols;Perchlorate;Limit sensory stimulation;Other, specify;Carbidopa, specify | Alphanumeric |
Choose all that apply |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Multiple Pre-Defined Values Selected |
||||||||
| C18711 | Imaging radioligand type other text | ImgRadiolgndTypOTH | The free-text field related to 'Imaging radioligand type' specifying other text. Isotope-labeled bioactive compound (generic or common name) used in the imaging scan | The free-text field related to 'Imaging radioligand type' specifying other text. Isotope-labeled bioactive compound (generic or common name) used in the imaging scan | Other, specify | Alphanumeric |
Choose only one |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-21 15:27:41.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08264 | Imaging raw data reconstruction method type | ImgRawDataReconstructMthdTyp | The type of method used for reconstruction of raw data from the imaging scan | The type of method used for reconstruction of raw data from the imaging scan | Reconstruction of raw data | Iterative;Filtered back projection;Other, specify | Iterative;Filtered back projection;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59042 | Imaging radioligand type dihydrotetrabenazine specify text | ImgRadiolgndTypDTBZSpecifyTxt | The free-text field related to 'Imaging radioligand type', specifying dihydrotetrabenazine (DTBZ) isotope details. Isotope-labeled bioactive compound (generic or common name) used in the imaging scan | The free-text field related to 'Imaging radioligand type', specifying dihydrotetrabenazine (DTBZ) isotope details. Isotope-labeled bioactive compound (generic or common name) used in the imaging scan | DTBZ, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 15:21:12.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C18048 | Imaging visual analysis blinded other text | ImgVisAnalyBlindOthrTxt | Specify in text whether the visual analysis of imaging was performed blinded to clinical data if the answer is not listed above | Specify in text whether the visual analysis of imaging was performed blinded to clinical data if the answer is not listed in 'Imaging visual analysis blinded indicator' | Was the visual analysis performed blinded to clinical data? Specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 4.00 | 2022-07-25 13:44:36.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 255 |
Free-Form Entry |
|||||||||
| C59053 | Imaging quantitative outcome indicator | ImgQuantOutcmeInd | Indicator of use of a quantitative outcome to describe tracer distribution and uptake for the imaging data analysis | Indicator of use of a quantitative outcome to describe tracer distribution and uptake for the imaging data analysis | Quantitative Imaging Outcome | No;Yes | No;Yes | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 1.00 | 2022-07-22 11:26:30.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C08251 | Imaging post injection management type | ImgPstInjMgtTyp | The type of special management post injection prior to image acquisition | The type of special management post injection prior to image acquisition | Post Injection Management prior to scan | No special management required;Quiet room;Eyes Open;Other, specify | No special management required;Quiet room;Eyes Open;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C18712 | Imaging raw data reconstruction method other text | ImgRawDataReconstructMthdOTH | The free-text field related to 'Imaging raw data reconstruction method type' specifying other text. The type of method used for reconstruction of raw data from the imaging scan | The free-text field related to 'Imaging raw data reconstruction method type' specifying other text. The type of method used for reconstruction of raw data from the imaging scan | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2014-05-27 13:34:46.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08265 | Imaging attenuation correction method type | ImgAttenuCorrectMethdTyp | Type of method to correct for different tissues density when analyzing the image | Type of method to correct for different tissues density when analyzing the image | Attenuation Correction | Homogeneous;Inhomogeneous;Other, specify | Homogeneous;Inhomogeneous;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.10 | 2022-08-15 12:39:13.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59043 | Imaging camera type | ImgCameraTyp | Type of imaging camera used | Type of imaging camera used | Camera | PET;SPECT;Other, specify;PET/CT;PET MRI;SPECT/CT | PET;SPECT;Other, specify;PET/CT;PET MRI;SPECT/CT | Alphanumeric |
No instructions available. |
No references available. | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 16:08:18.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C18692 | Imaging attenuation correction method type other text | ImgAttenuCorrectMethdTypOTH | The free-text field related to 'Imaging attenuation correction method type' specifying other text. The type of method to correct for different tissues density when analyzing the image | The free-text field related to 'Imaging attenuation correction method type' specifying other text. The type of method to correct for different tissues density when analyzing the image | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-22 13:58:14.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C59054 | Imaging quantitative outcome dopamine transporter radioligand type | ImgQuanOutDATRadiolgndTyp | Type of dopamine transporter (DAT) radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | Type of dopamine transporter (DAT) radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | DAT | Ioflupane (SPECT);IACFT (SPECT);β-CIT;CFT (PET) | Ioflupane (SPECT);IACFT (SPECT);β-CIT;CFT (PET) | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 1.00 | 2022-07-22 11:28:08.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C08253 | Imaging visual analysis status | ImgVisAnlysisStatus | Status of findings from subjective review of image data | Status of findings from subjective review of image data | Visual Analysis | Normal;Abnormal;Other, specify | Normal;Abnormal;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C18716 | Imaging scanner manufacturer name other text | ImgScannerManufNameOTH | The free-text field related to 'Imaging scanner manufacturer name', specifying other text. Name of manufacturer of imaging scanner | The free-text field related to 'Imaging scanner manufacturer name', specifying other text. Name of manufacturer of imaging scanner | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-06-28 13:09:35.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08266 | Imaging post reconstruction filter type | ImgPstReconstrctFltrTyp | Type of post reconstruction filter used to smooth image data | Type of post reconstruction filter used to smooth image data | Post Reconstruction Filter | Butterworth;Lowpass | Butterworth;Lowpass | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59044 | Imaging camera type other text | ImgCameraTypOTH | The free-text field related to 'Imaging camera type', specifying other text. Type of imaging camera used | The free-text field related to 'Imaging camera type', specifying other text. Type of imaging camera used | Other, specify | Alphanumeric |
No instructions available. |
No references available. | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 16:13:22.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C59055 | Imaging quantitative outcome vesicular monoamine transporter 2 radioligand type | ImgQuanOutVMAT2RadiolgndTyp | Type of vesicular monoamine transporter 2 (VMAT2) radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | Type of vesicular monoamine transporter 2 (VMAT2) radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | VMAT2 | AV133;DTBZ | AV133;DTBZ | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 1.00 | 2022-07-22 11:31:51.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C18698 | Imaging F-dopa binding ratio type other text | ImgFdopaBindRatTypOTH | The free-text field related to 'Imaging F-dopa binding ratio type' specifying other text. Type of F-dopa binding ratio with respect to the rest of the brain | The free-text field related to 'Imaging F-dopa binding ratio type' specifying other text. Type of F-dopa binding ratio with respect to the rest of the brain | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 2.00 | 2022-07-22 16:20:47.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08254 | Imaging visual analysis location performed type | ImgVisAnlysisLocPerfTyp | Type of location where visual analysis of the imaging data are performed | Type of location where visual analysis of the imaging data are performed | Where visual analysis was performed | Central;Other, specify;Local - Site | Central;Other, specify;Local - Site | Alphanumeric |
Choose one |
No references available | Adult | Supplemental-Highly Recommended | 3.10 | 2022-07-22 15:18:03.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Multiple Pre-Defined Values Selected |
||||||||
| C18720 | Imaging visual analysis location performed type other text | ImgVisAnlysisLocPerfTypOTH | The free-text field related to 'Imaging visual analysis location performed type' specifying other text. Location where visual analysis of the imaging data are performed | The free-text field related to 'Imaging visual analysis location performed type' specifying other text. Location where visual analysis of the imaging data are performed | Other, specify | Alphanumeric |
Choose one |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-22 15:20:37.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08267 | Imaging outcome variable name | ImgOutcomeVarName | Name of the primary imaging outcome variable | Unit of measure used to specify the length of time medication(s) were withheld from the subject pre-treatment for the imaging scan | Imaging Outcome | Volume of interest;Voxel based;Other, specify | Volume of interest;Voxel based;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59045 | Imaging pre-scan procedure type carbidopa specify text | ImgPrescnProcdrTypCarbSpcfyTxt | The free-text field related to 'Imaging pre-scan procedure type', specifying Carbidopa details. Type(s) of pre-scan procedures administered to the participant/subject | The free-text field related to 'Imaging pre-scan procedure type', specifying Carbidopa details. Type(s) of pre-scan procedures administered to the participant/subject | Carbidopa, specify | Alphanumeric |
No instructions available. |
No references available. | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 16:15:18.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C59056 | Imaging quantitative outcome tyrosine hydroxylase radioligand type | ImgQuanOutTyrHydRadiolgndTyp | Type of tyrosine hydroxylase radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | Type of tyrosine hydroxylase radioligand used for the quantitative imaging outcome to describe tracer distribution and uptake for the imaging data analysis being documented. | Tyrosine Hydroxylase | Fluoro-metatyrosine (FMT) | Fluoro-metatyrosine (FMT) | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental | 1.00 | 2022-07-22 11:37:33.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C01541 | Weight measurement | WgtMeasr | Measurement of participant's weight | Measurement of participant's weight | Current Body Weight | Numeric Values |
Record the weight of the participant/subject in kilograms (kg). To be collected at the visit, not self-reported. |
No references available | Adult | Supplemental-Highly Recommended | 3.10 | 2024-02-29 15:49:21.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Free-Form Entry |
0 | 500 | kilogram | 2179689 | ||||||
| C18699 | Imaging isotope type other text | ImgIsotopeTypOTH | The free-text field related to 'Imaging isotope type' specifying other text. Type of radioactive isotope used for the imaging scan | The free-text field related to 'Imaging isotope type' specifying other text. Type of radioactive isotope used for the imaging scan | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-21 15:39:03.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08255 | Imaging visual analysis blinded indicator | ImgVisAnlysisBlindInd | Indicator of whether the visual analysis was performed blinded to clinical data | Indicator of whether the visual analysis was performed blinded to clinical data | Was the visual analysis performed blinded to clinical data? | Yes;No;Unknown | Yes;No;Unknown | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-25 08:54:08.2 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C18721 | Imaging visual analysis status other text | ImgVisAnlysisStatOTH | The free-text field related to 'Imaging visual analysis status' specifying other text. Status of findings from subjective review of image data | The free-text field related to 'Imaging visual analysis status' specifying other text. Status of findings from subjective review of image data | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-22 15:16:46.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
|||||||||
| C08268 | Imaging volume of interest placement method type | ImgVOIPlacementMthdTyp | Type of method used for volume of interest (VOI) placement for the imaging data analysis | Type of method used for volume of interest (VOI) placement for the imaging data analysis | Method for VOI placement | Automated;Subjective Placement;Other, specify | Automated;Subjective Placement;Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-07-22 09:34:41.527 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Single Pre-Defined Value Selected |
||||||||
| C59046 | Imaging observe method status | ImgObserveMethdStat | Status related to the method of observation of participant/subject during scan | Status related to the method of observation of participant/subject during scan | Status of participant during scan | Directly observed;Movements recorded | Directly observed;Movements recorded | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 1.00 | 2022-07-21 16:24:43.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Multiple Pre-Defined Values Selected |
||||||||
| C59057 | Imaging amyloid centiloid anatomic site | ImgAmyloidCentiloidAnatSite | Anatomic site(s) for which quantitative estimations of amyloid plaque obtained by imaging were recorded using, or were scaled to, the Centiloid scale. | Anatomic site(s) for which quantitative estimations of amyloid plaque obtained by imaging were recorded using, or were scaled to, the Centiloid scale. | Amyloid Imaging Centiloids | Neocortex;Posterior cingual/precuneus;Frontal;Parietal;Lateral;Temporal;Mesiotemporal;Anterior cingulate;Striatum;Cerebellar gray;Whole cerebellum;Other, specify | Neocortex;Posterior cingual/precuneus;Frontal;Parietal;Lateral;Temporal;Mesiotemporal;Anterior cingulate;Striatum;Cerebellar gray;Whole cerebellum;Other, specify | Alphanumeric |
No instructions available |
Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4. doi: 10.1016/j.jalz.2014.07.003. Epub 2014 Oct 28. PMID: 25443857; PMCID: PMC4300247. | Adult | Supplemental | 1.00 | 2022-07-22 11:40:19.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations |
Multiple Pre-Defined Values Selected |
||||||||
| C02014 | Medication prior or concomitant name | MedctnPriorConcomName | Name of the prior/concomitant agent or drug administered | Name of the prior/concomitant agent or drug administere | Parkinson's Disease (PD) Medication | Alphanumeric |
Only answer if 'Yes' is answered for 'PD medications' |
No references available | Adult | Supplemental-Highly Recommended | 3.00 | 2013-08-28 16:08:00.453 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 4000 |
Free-Form Entry |
3162728 | ||||||||
| C18700 | Imaging matrix size value other text | ImgMatrixSizeValOTH | The free-text field related to 'Imaging matrix size value', specifying other text. Value representing the imaging matrix size in millimeters | The free-text field related to 'Imaging matrix size value', specifying other text. Value representing the imaging matrix size in millimeters | Other, specify | Alphanumeric |
No instructions available |
No references available | Adult | Supplemental-Highly Recommended | 2.00 | 2022-07-01 16:00:38.0 | PET-SPECT Localization | Imaging Diagnostics | Assessments and Examinations | 50 |
Free-Form Entry |
